Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KHDRBS1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
mRNA | SRSF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
mRNA | ZBTB4 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | CTSA | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
mRNA | B4GALT7 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |